FDA inspection
Hybrid Pharma LLC: FDA inspection ending Nov 9, 2023
FDA inspection 1222392 · Official Action Indicated (OAI) · Deerfield Beach, FL
Key facts
| Inspection ID | 1222392 |
|---|---|
| Firm | Hybrid Pharma LLC |
| FEI number | 3011319445 |
| Address | 1015 W Newport Center Dr Ste 106a |
| City | Deerfield Beach |
| State | FL |
| ZIP | 33442 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Nov 9, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data